Onyx uses AI to integrate genomics, transcriptomics, proteomics, and metabolomics with patient clinical histories. Nearly 1,000 people have already joined the collective's research studies to provide the longitudinal data needed to transform life sciences into an engineering discipline and develop more effective precision medicines.
Wednesday, October 21, 2026
Story
Onyx Raises $8M Seed to Build AI Virtual Immune System
Startups13 days ago
A biological research group is launching a project to map the human body's responses to infection and inflammation. The startup, known as Onyx, raised $8M in an oversubscribed seed round led by Dimension Capital to create what it calls a virtual immune system. Other investors participating in the round include Haystack VC, Refactor, Standard VC, and Robot Ventures.
Looking for more context or analysis?
Tilt chat provides reliable, tailored insights, alerts, and automations.